These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8840812)

  • 1. [Causative agent of impetigo: staphylococcal exfoliative toxin and regulation of the toxin production in Staphylococcus aureus].
    Sakurai S
    Nihon Saikingaku Zasshi; 1996 Aug; 51(3):813-22. PubMed ID: 8840812
    [No Abstract]   [Full Text] [Related]  

  • 2. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals.
    Nishifuji K; Sugai M; Amagai M
    J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of Staphylococcus aureus exfoliative toxin.
    Al-Sulami AA; Al-Rubiay KK; Affat AM
    East Mediterr Health J; 2001; 7(1-2):121-7. PubMed ID: 12596961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation.
    Nishifuji K; Shimizu A; Ishiko A; Iwasaki T; Amagai M
    J Dermatol Sci; 2010 Sep; 59(3):184-91. PubMed ID: 20728315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins.
    Yamasaki O; Yamaguchi T; Sugai M; Chapuis-Cellier C; Arnaud F; Vandenesch F; Etienne J; Lina G
    J Clin Microbiol; 2005 Apr; 43(4):1890-3. PubMed ID: 15815014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis.
    Kanzaki H; Ueda M; Morishita Y; Akiyama H; Arata J; Kanzaki S
    Dermatology; 1997; 195(1):6-9. PubMed ID: 9267729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal Scalded Skin Syndrome Caused by a Rare Variant of Exfoliative-toxin-A+ S. aureus in an Adult Immunocompromised Woman.
    Saluzzo S; Layer F; Stingl G; Stary G
    Acta Derm Venereol; 2018 Jan; 98(1):138-139. PubMed ID: 28853493
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France.
    Yamasaki O; Tristan A; Yamaguchi T; Sugai M; Lina G; Bes M; Vandenesch F; Etienne J
    Clin Microbiol Infect; 2006 Jun; 12(6):585-8. PubMed ID: 16700711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal scalded skin syndrome caused by exfoliative toxin B-producing methicillin-resistant Staphylococcus aureus.
    Yokota S; Imagawa T; Katakura S; Mitsuda T; Arai K
    Eur J Pediatr; 1996 Aug; 155(8):722. PubMed ID: 8839735
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbiologic characteristics of exfoliative toxin-producing Staphylococcus aureus.
    Murono K; Fujita K; Yoshioka H
    Pediatr Infect Dis J; 1988 May; 7(5):313-5. PubMed ID: 3380582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcal scalded skin syndrome in an adult. Identification of exfoliative toxin A and B genes by polymerase chain reaction.
    Oono T; Kanzaki H; Yoshioka T; Arata J
    Dermatology; 1997; 195(3):268-70. PubMed ID: 9407177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exfoliative toxins of Staphylococcus aureus.
    Bukowski M; Wladyka B; Dubin G
    Toxins (Basel); 2010 May; 2(5):1148-65. PubMed ID: 22069631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exfoliative toxin A-converting phage isolated from Staphylococcus aureus strain ZM.
    Yoshizawa Y; Sakurada J; Sakurai S; Machida K; Kondo I; Masuda S
    Microbiol Immunol; 2000; 44(3):189-91. PubMed ID: 10789506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.
    Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR
    Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lesional or non lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns.
    Capoluongo E; Giglio A; Belardi M; Leonetti F; Frasca A; Giannetti A; Ameglio F
    New Microbiol; 2000 Jan; 23(1):21-7. PubMed ID: 10946402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes.
    Courjon J; Hubiche T; Phan A; Tristan A; Bès M; Vandenesch F; Etienne J; Del Giudice P; Gillet Y
    Pediatr Infect Dis J; 2013 Jul; 32(7):727-30. PubMed ID: 23446443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus.
    Ladhani S
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):181-9. PubMed ID: 14625102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal epidermolysins.
    Prévost G; Couppié P; Monteil H
    Curr Opin Infect Dis; 2003 Apr; 16(2):71-6. PubMed ID: 12734438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of clinical S. aureus-isolates for the production of exfoliative toxin. A methodological study.
    Elsner P; Hartmann AA; Lenz W; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):216-20. PubMed ID: 3936308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B.
    Hisatsune J; Hirakawa H; Yamaguchi T; Fudaba Y; Oshima K; Hattori M; Kato F; Kayama S; Sugai M
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6131-40. PubMed ID: 24080652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.